Related Experiment Video
Updated: Jan 23, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Hippo Signaling in Cancer: Lessons From Drosophila Models
Kirti Snigdha1, Karishma Sanjay Gangwani1, Gauri Vijay Lapalikar2
1Department of Biology, University of Dayton, Dayton, OH, United States.
Abstract:
Hippo pathway was initially identified through genetic screens for genes regulating organ size in fruitflies. Recent studies have highlighted the role of Hippo signaling as a key regulator of homeostasis, and in tumorigenesis. Hippo pathway is comprised of genes that act as tumor suppressor genes like hippo (hpo) and warts (wts), and oncogenes like yorkie (yki). YAP and TAZ are two related mammalian homologs of Drosophila Yki that act as effectors of the Hippo pathway. Hippo signaling deficiency can cause YAP- or TAZ-dependent oncogene addiction for cancer cells. YAP and TAZ are often activated in human malignant cancers. These transcriptional regulators may initiate tumorigenic changes in solid tumors by inducing cancer stem cells and proliferation, culminating in metastasis and chemo-resistance. Given the complex mechanisms (e.g., of the cancer microenvironment, and the extrinsic and intrinsic cues) that overpower YAP/TAZ inhibition, the molecular roles of the Hippo pathway in tumor growth and progression remain poorly defined. Here we review recent findings from studies in whole animal model organism like Drosophila on the role of Hippo signaling regarding its connection to inflammation, tumor microenvironment, and other oncogenic signaling in cancer growth and progression.
Insights
The Hippo pathway regulates organ size and is crucial in tumorigenesis. Its dysregulation, particularly YAP/TAZ activation, drives cancer progression, metastasis, and chemo-resistance, with complex roles in the tumor microenvironment.
Area of Science:
- Oncology
- Developmental Biology
- Cell Signaling
Background:
- The Hippo pathway, identified in fruit flies, regulates organ size and homeostasis.
- It involves tumor suppressor genes (e.g., hippo, warts) and oncogenes (e.g., yorkie).
- Mammalian YAP and TAZ are key effectors, often activated in human cancers.
Purpose of the Study:
- To review the role of Hippo signaling in cancer growth and progression.
- To explore connections between Hippo signaling, inflammation, and the tumor microenvironment.
- To elucidate the molecular mechanisms of Hippo pathway involvement in tumorigenesis.
Main Methods:
- Review of recent findings from studies, including those in the model organism *Drosophila*.
- Analysis of the role of Hippo signaling in relation to inflammation and tumor microenvironment.
- Examination of interactions with other oncogenic signaling pathways.
Main Results:
- Hippo signaling deficiency can lead to YAP/TAZ-dependent oncogene addiction in cancer cells.
- Activated YAP and TAZ are implicated in inducing cancer stem cells, proliferation, metastasis, and chemo-resistance.
- Complex mechanisms involving the tumor microenvironment and signaling cues can override YAP/TAZ inhibition.
Conclusions:
- The Hippo pathway plays a significant role in cancer, with YAP/TAZ activation being a key driver.
- Understanding Hippo signaling's intricate connections to inflammation and the tumor microenvironment is crucial for defining its role in cancer progression.
- Further research is needed to fully define the molecular roles of the Hippo pathway in tumor growth and therapeutic resistance.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small-signal Diode Model
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
What is Cell Signaling?
Endocrine Signaling
Bacterial Signaling

